Press Releases

Information on the Total Number of Voting Rights (Denominator) Following the Completion of the LDA Capital Increase
30 June 2022
EN FR

Mithra Completes the EUR 23.5 Million Private Placement
24 June 2022
EN FR

Mithra Announces Details of EUR 23.5 Million Private Placement
21 June 2022
EN FR

Mithra Announces Intention to Proceed with Private Placement
20 June 2022
EN FR

Mithra Announces the Resignation of François Fornieri As Non-Executive Director
20 June 2022
EN FR

Publication of Transparency Notifications Received from Goldman Sachs
13 June 2022
EN FR

Exercise of a Call Option from Goldman Sachs and Additional Information on the Financing Strategy
2 June 2022
EN FR

Mithra Issues a Put Option Notice Under Capital Agreement with LDA Capital
13 May 2022
EN FR

Presentation of Donesta® Phase 3 Topline Efficacy Results at the 20th ISGE World Congress
12 May 2022
EN FR

Publication of a Transparency Notification Received from Glenernie Capital
6 May 2022
EN FR

Publication of Transparency Notifications Received from Goldman Sachs
29 April 2022
EN FR

Mithra CDMO Announces Collaboration with MedinCell for the Development of Injectable Products for Malaria and Transplant Rejection
26 April 2022
EN FR

Information on the Total Number of Voting Rights (denominator) following Exercise of a Call Option from Goldman Sachs
20 April 2022
EN FR

Mithra Releases Invitation to its General Ordinary and Extraordinary Securities holders’ Meeting
19 April 2022
EN FR

Mithra Announces the Extension of the Capital Commitment Agreement with LDA Capital by Two Years and the Increase of the Commitment by EUR 25 million
18 April 2022
EN FR

Mithra Releases 2021 Annual Report
15 April 2022
EN FR

Mithra Announces Improved Consolidated Topline Results from Donesta® Phase 3 Studies and Launch of Recruitment for the Extension of European Study
14 April 2022
EN FR

Publication of a Transparency Notification Received from Goldman Sachs
8 April 2022
EN FR

Publication of a Transparency Notification Received from François Fornieri
29 March 2022
EN FR

Publication of a Transparency Notification Received from Goldman Sachs
29 March 2022
EN FR

Publication of a Transparency Notification Received from Goldman Sachs
23 March 2022
EN FR

Exercise of a Second Drawing Request under Equity Funding Agreement with Goldman Sachs
21 March 2022
EN FR

Mithra Reports Full Year 2021 Financial Results
8 March 2022
EN FR

Publication of a Transparency Notification Received from François Fornieri
28 February 2022
EN FR

Publication of a Transparency Notification Received from Alychlo
25 February 2022
EN FR

Publication of a Transparency Notification Received from Goldman Sachs
25 February 2022
EN FR

Mithra to Host Webcast for 2021 Financial Results on 8 March 2022
21 February 2022
EN FR

Mithra and Searchlight Pharma Announce Launch of Haloette® in Canada
16 February 2022
EN FR

Publication of a Transparency Notification Received from François Fornieri
16 February 2022
EN FR

Information on the Total Number of Voting Rights (Denominator) Following the Completion of the LDA Capital Increase
14 February 2022
EN FR

Mithra Obtains Equity Funding for up to EUR 100 Million
7 February 2022
EN FR

Mithra Announces Positive Top-Line Results from Donesta® Phase 3 Studies in Menopausal Women
14 January 2022
EN FR

Mithra Announces 2022 Financial Calendar
13 January 2022
EN FR

Publication of a Transparency Notification Received from François Fornieri
10 January 2022
EN FR